Stifel Financial’s Repare Therapeutics RPTX Stock Holding History

Stifel Financial’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$26K	–	3733
2025 Q4	$26K	Sell	10,000 -67,600	-87%	-$136K	﹤0.01%	3552
2025 Q3	$137K	Sell	77,600 -3,000	-4%	-$4.8K	﹤0.01%	3410
2025 Q2	$112K	Hold	80,600	–	–	﹤0.01%	3352
2025 Q1	$79.5K	Sell	80,600 -8,900	-10%	-$10.7K	﹤0.01%	3312
2024 Q4	$117K	Buy	89,500 +37,800	+73%	+$113K	﹤0.01%	3235
2024 Q3	$178K	Buy	51,700 +13,800	+36%	+$45.4K	﹤0.01%	3164
2024 Q2	$125K	Buy	37,900 +7,500	+25%	+$26.7K	﹤0.01%	3182
2024 Q1	$143K	Buy	+30,400	New	+$195K	﹤0.01%	3141

Stifel Financial's RPTX Position: Q1 2026 in Review

Stifel Financial sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 10,000 shares — an estimated $26K sold.

Stifel Financial first reported a position in RPTX in Q1 2024 and held it in 8 quarters. The position peaked at $178K in Q3 2024. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Stifel Financial reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Stifel Financial sold 10,000 Repare Therapeutics shares in Q1 2026, an estimated $26K.
Stifel Financial first reported a position in Repare Therapeutics in Q1 2024 and held it in 8 quarters.
Stifel Financial's Repare Therapeutics position peaked at $178K in Q3 2024.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.